_open-enrollment-consider-uc-san-diego-health-preview-1.jpg "Open Enrollment: Consider UC San Diego Health from uc san diego medical center la jolla ca Video Screenshot Preview 1")
Gallery_open-enrollment-consider-uc-san-diego-health-preview-3.jpg "Open Enrollment: Consider UC San Diego Health from uc san diego medical center la jolla ca Video Screenshot Preview 3")
Gallery_open-enrollment-consider-uc-san-diego-health-preview-hqdefault.jpg "Open Enrollment: Consider UC San Diego Health from uc san diego medical center la jolla ca Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 1 minute 43 seconds
👁 View: 501 times
Play Audio:👁 View: 501 times
Description:
UC San Diego Health
UC San Diego Health
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_everything-you-need-to-know-about-the-uc-schools.webp "Victor Lai")
_neck-pain-home-exercises-124-uc-san-diego-health.webp "UC San Diego Health")
_how-are-cll-patients-monitored-after-a-clinical-trial-concludes.webp "What happens after a clinical trial is complete? CLL expert Dr. Michael Choi explains how participants are monitored during clinical trial follow-up. nnDr. Michael Choi is a hematologist and medical oncologist at UC San Diego Moores Cancer Center. For more information on Dr. Choi, visit: https://providers.ucsd.edu/details/11958/hematology-blood-diseases-cancer")
_dozens-of-patients-at-ucsd-health-la-jolla-in-39hallway-er39.webp "CBS 8 San Diego")
_oral-pah-medications-session-2.webp "Chair: Christine Archer-Chicko, MSN, CRNP nPenn – Presbyterian Medical Center nnRichard Channick, MDnUC San Diego Medical Center, Calif nnLouise Durst, RN nMayo Clinic, Minn. nnThis session will review current oral PAH medications including calcium channel antagonists, endothelin receptor antagonists and phosphodiesterase inhibitors. The panelists will provide a comprehensive overview of these therapies including the mechanism of action, indications, dosing, side effects and special considerat")
_defining-the-future-of-uc-san-diego-health.webp "UC San Diego Health")
_what-it-means-to-be-san-diego39s-only-comprehensive-cancer-center.webp "UC San Diego Health")
_how-is-a-patients-safety-monitored-in-a-cll-clinical-trial.webp "CLL clinical trials have safety protocols, but how are they carried out? CLL expert Dr. Michael Choi explains the frequency of monitoring, what happens if adverse events occur, and the groups that oversee clinical trial safety. nnDr. Michael Choi is a hematologist and medical oncologist at UC San Diego Moores Cancer Center. For more information on Dr. Choi, visit: https://providers.ucsd.edu/details/11958/hematology-blood-diseases-cancer")
_everything-you-need-to-know-about-the-uc-schools.jpg)
_neck-pain-home-exercises-124-uc-san-diego-health.jpg)
_how-are-cll-patients-monitored-after-a-clinical-trial-concludes.jpg)
_dozens-of-patients-at-ucsd-health-la-jolla-in-39hallway-er39.jpg)
_oral-pah-medications-session-2.jpg)
_defining-the-future-of-uc-san-diego-health.jpg)
_what-it-means-to-be-san-diego39s-only-comprehensive-cancer-center.jpg)
_how-is-a-patients-safety-monitored-in-a-cll-clinical-trial.jpg)
![[+]](/images/menu.gif){kind=small}